Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-17 5:31 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 39,384 | $0.70064 | $27,594 | 44,848 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:31 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 20,563 | $0.68601 | $14,106 | 19,257 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:30 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 22,795 | $0.69703 | $15,889 | 19,015 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:30 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 23,589 | $0.69622 | $16,423 | 20,201 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 11,808 | $0.84819 | $10,015 | 11,841 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 9,229 | $0.84654 | $7,813 | 7,874 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 29,202 | $0.84698 | $24,734 | 26,388 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 9,229 | $0.84654 | $7,813 | 7,874 (Direct) | View |
| 2023-09-01 Sale | 2023-09-01 7:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,403 | $0.78 | $1,874 | 3,449 (Direct) | View |
| 2023-08-01 Sale | 2023-08-01 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 3,096 | $0.9056 | $2,804 | 4,718 (Direct) | View |
| 2023-07-10 Sale | 2023-07-10 5:01 pm | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 47,702 | $0.9108 | $43,447 | 75,056 (Direct) | View |
| 2023-06-27 Sale | 2023-06-27 9:15 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,333 | $0.92 | $2,146 | 3,519 (Direct) | View |
| 2023-01-31 Sale | 2023-01-31 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 11,890 | $1.8696 | $22,230 | 19,535 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-26 12:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | EcoR1 Capital LLC 10% Owner | 0 | $0 | 164,424,420 (Indirect) | View |
| 2024-03-18 Option Award | 2024-03-18 5:00 pm | N/A 2034-03-18 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 6,219,696 | $0 | 6,219,696 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:06 pm | 2025-01-15 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 40,950 | $0 | 40,950 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:03 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:03 pm | 2025-01-15 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Hege Kristen Director | 81,906 | $0 | 81,906 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:02 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:02 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:00 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 9,329,568 | $0 | 9,329,568 (Direct) | View |
Ownership | 2023-11-01 5:00 pm | N/A 2033-11-01 | Adaptimmune Therapeutics PLC | ADAP | Hege Kristen Director | 0 | $0 | 1,000,000 (Direct) | View |
| 2023-07-05 Option Award | 2023-07-05 5:05 pm | N/A 2031-08-24 | Adaptimmune Therapeutics PLC | ADAP | Hegde Priti Director | 488,586 | $0 | 488,586 (Direct) | View |
| 2023-07-05 Option Award | 2023-07-05 5:03 pm | N/A 2028-12-12 | Adaptimmune Therapeutics PLC | ADAP | Allen Andrew R Director | 547,296 | $0 | 547,296 (Direct) | View |
| 2023-07-05 Option Award | 2023-07-05 5:00 pm | N/A 2024-03-15 | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 10,848,678 | $0 | 10,848,678 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:16 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 933,317 | $0 | 933,317 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:04 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Hegde Priti Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:04 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Furey John Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:03 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 981,463 | $0 | 981,463 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:02 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 933,317 | $0 | 933,317 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:02 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 1,077,756 | $0 | 1,077,756 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:01 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director | 1,462,927 | $0 | 1,462,927 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:00 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Allen Andrew R Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-01 4:59 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 611,224 | $0 | 410,578 (Indirect) | View |